Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: Relationship to transporter occupancy determined by positron emission tomography neuroimaging

Journal of Pharmacology and Experimental Therapeutics

Volumn 309, Issue 3, 2004, Pages 959-969

  Lindsey, Kimberly P ^a   Wilcox, Kristin M ^a   Votaw, John R ^b   Goodman, Mark M ^b   Plisson, Christophe ^b   Carroll, F Ivy ^c   Rice, Kenner C ^d   Howell, Leonard L ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RTI INTERNATIONAL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (3' METHYL 4 CHLOROPHENYL)TROPANE 2BETA CARBOXYLIC ACID METHYL ESTER TARTRATE; 3BETA (4 CHLOROPHENYL)TROPANE 2BETA (3 PHENYLISOXAZOL 5 YL) DERIVATIVE; 8 (2 FLUOROETHYL) 2BETA CARBOMETHOXY 3BETA (4 CHLOROPHENYL)NORTROPANE F 18; BLOCKING AGENT; COCAINE; DOPAMINE TRANSPORTER; DOPAMINE TRANSPORTER INHIBITOR; RTI 112; RTI 177; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; MALE; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; RHESUS MONKEY;

ANESTHESIA; ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; DISEASE MODELS, ANIMAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOPAMINE UPTAKE INHIBITORS; ISOFLURANE; MACACA MULATTA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT MODULATORS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; SELF ADMINISTRATION; TOMOGRAPHY, EMISSION-COMPUTED; TROPANES;

EID: 2442695268     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.060293     Document Type: Article

References (41)

1. Adachi Y, Taoda M, Uchihashi Y, Watanabe K, and Satoh T (1999) The effect of sevoflurane and ioflurane on striatal dopamine of awake freely moving rats observed in an in vivo microdialysis study. Masui 48:960-965.
2. Anderson PH (1989) The dopamine uptake inhibitor GBR 2909: selectivity and molecular mechanism of action. Eur J Pharmacol 166:493-504.
3. Bergman J, Madras BK, Johnson SE, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
4. Carroll FI, Howell LL, and Kuhar MJ (1999) Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem 42:2721-2736.
5. Carroll FI, Kuzemko MA, Gao Y, Abraham P, Lewin AH, Boja JW, and Kuhar MJ (1992) Synthesis and ligand binding of 3β-(3-substituted phenyl)- and 3β-(3,4-disubstituted phenyl)tropane-2β-carboxylic acid methyl esters. Med Chem Res 1:382-387.
6. Czoty PW, Ginsburg BC, and Howell LL (2002) Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 300:831-837.
7. Glowa JR and Fantegrossi WE (1997) Effects of dopaminergic drugs on food- and cocaine-maintained responding. IV: Continuous cocaine infusions. Drug Alcohol Depend 45:71-79.
8. Glowa JR and Wojnicki FHE (1996) Effects of drugs on food- and cocaine-maintained responding. III. Dopaminergic antagonists. Psychopharmacology 128:351-358.
9. Glowa JR, Wojnicki FHE, Matecka D, and Bacher JD (1995) Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine. Exp Clin Psychopharmacol 3:219-231.
10. Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, et al. (2003) Synthesis and characterization of iodine-123 labeled 2β-carbomethoxy-3β-(4′ -((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography. J Med Chem 46:925-935.
11. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Nucl Med Biol 27:1-12.
12. Grabowski J, Rhodes H, Elk R, Schmitz J, Davis C, Creson D, and Kirby K (1995) Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled, double-bind trials. J Clin Psychopharmacol 15:163-174.
13. Howell LL and Byrd LD (1991) Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258:178-185.
14. Howell LL and Byrd LD (1995) Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 275:1551-1559.
15. Howell LL, Czoty PW, Kuhar MJ, and Carroll FI (2000) Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. J Pharmacol Exp Ther 29:521-529.
16. Howell LL, Hoffman JM, Votaw JR, Landrum AM, and Jordan JF (2001) An apparatus and behavioral training protocol to conduct positron emission tomography (PET) neuroimaging in conscious rhesus monkeys. J Neurosci Methods 106:161-169.
17. Howell LL, Hoffman JM, Votaw JR, Landrum AM, Wilcox KM, and Lindsey KP (2002) Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys. Psychopharmacology 159:154-160.
18. Howell LL and Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1-6.
19. Kimmel HL, Carroll FI, and Kuhar MJ (2001) Locomotor stimulant effects of novel phenyltropanes in the mouse. Drug Alcohol Depend 65:25-36.
20. Kleven MS and Woolverton WL (1993) Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol Depend 31:149-158.
21. Kotian P, Abraham P, Lewin AH, Masearella SW, Boja JW, Kuhar MJ, and Carroll FI (1995) Synthesis and ligand binding study of 3β-(4′ -substituted phenyl)-2β-heterocyclic)tropanes. J Med Chem 38:3451-3453.
22. Kuhar MJ, McGirr KM, Hunter RG, Lambert PD, Garrett BE, and Carroll FI (1999) Studies of selected phenyltropanes at monoamine transporters. Drug Alcohol Depend 56:9-15.
23. Kuhar MJ, Ritz MC, and Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299-302.
24. Li HH and Votaw JR (1998) Optimization of PET activation studies based on the SNR measured in the 3-D Hoffman brain phantom. IEEE Trans Med Imaging 17:596-605.
25. Lile JA, Wang Z, Woolverton WL, France JE, Gregg TC, Davies HM, and Nader MA (2003) The reinforcing efficacy of paychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics. J Pharmacol Exp Ther 307:356-366.
26. Mello NK, Lukas SE, Bree MP, and Mendelson JH (1990) Desipramine effects on cocaine self-administration by rhesus monkeys. Drug Alcohol Depend 26:103-116.
27. Mello NK and Negus SS (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14:375-424.
28. Nader MA, Grant KA, Davies MLH, Mach RH, and Childers SR (1997) The reinforcing and discriminative stimulus effects of the novel cocaine analog 2β-propanoyl-3β-(4-tolyl)-tropane in rhesus monkeys. J Pharmacol Exp Ther 280:541-550.
29. Negus SS, Brandt MR, and Mello NK (1999) Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 291:60-69.
30. Panlilio LV, Goldberg SR, Gilman JP, Jufer R, Cone EJ, and Schindler CW (1998) Effects of delivery rate and non-contingent infusion of cocaine on cocaine self-administration in rhesus monkeys. Psychopharmacology 137:253-258.
31. Press WH, Flannery B, Teukolsky S, and Vetterling W (1988) Numerical Recipes in C: The Art of Scientific Computing. Cambridge University Press, New York.
32. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-adminiatration of cocaine. Science (Wash DC) 237:1219-1223.
33. Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N, and Nakanishi S (1999) Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR 12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. Brain Res 849:854-896.
34. 11C]WIN35,428 PET scans. Synapse 32:44-50.
35. Volkow ND, Gatley SJ, Fowler JS, Logan J, Fischman M, Gifford AN, Pappas N, King P, Vitkun S, Ding YS, et al. (1996) Cocaine doses equivalent to those abused by humans occupy most of the dopamine transporters. Synapse 24:399-402.
36. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, et al. (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (Lond) 386:827-830.
37. Votaw JR, Howell LL, Martarello L, Hoffman JM, Kilts CD, Lindsey KP, and Goodman MM (2002) Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNT. Synapse 44:203-210.
38. Weed MR, Mackevicius AS, Kebabian J, and Woolverton WL (1995) Reinforcing and discriminative stimulus effects of β-CIT in rhesus monkeys. Pharmacol Biochem Behav 51:953-956.
39. Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, and Howell LL (2002) Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse 43:78-85.
40. Wilcox KM, Paul IA, and Woolverton WL (1999) Comparison between dopamine transporter affinity and self-administration potency of local anesthetics in rhesus monkeys. Eur J Pharmacol 367:175-181.
41. Woolverton WL and Johnson KM (1992) Neurobiology of cocaine abuse. Trends Pharmacol Sci 13:193-200.